These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21834758)

  • 1. Tuberculosis; opportunities for treatment optimization.
    Alffenaar JW
    Curr Pharm Des; 2011; 17(27):2852. PubMed ID: 21834758
    [No Abstract]   [Full Text] [Related]  

  • 2. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensively drug-resistant tuberculosis, Lesotho.
    Satti H; Seung K; Keshavjee S; Furin J
    Emerg Infect Dis; 2008 Jun; 14(6):992-3. PubMed ID: 18551748
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.
    Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E
    Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates.
    Horita Y; Takii T; Yagi T; Ogawa K; Fujiwara N; Inagaki E; Kremer L; Sato Y; Kuroishi R; Lee Y; Makino T; Mizukami H; Hasegawa T; Yamamoto R; Onozaki K
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4140-5. PubMed ID: 22615274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug Therapy.
    Amaral L; van Soolingen D
    Recent Pat Antiinfect Drug Discov; 2015; 10(2):71-3. PubMed ID: 26235217
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Millán-Lou MI; Ollé-Goig JE; Tortola MT; Martin C; Samper S
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):150-3. PubMed ID: 26792464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trials to optimize treatment of multidrug-resistant tuberculosis.
    Mitnick CD; Castro KG; Harrington M; Sacks LV; Burman W
    PLoS Med; 2007 Nov; 4(11):e292. PubMed ID: 17988168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO strategies for the management of drug-resistant tuberculosis.
    Rendon A; Centis R; D'Ambrosio L; Migliori GB
    Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the revised definition of extensively drug-resistant tuberculosis.
    Veziris N; Bonnet I; Morel F; Guglielmetti L; Maitre T; Fournier Le Ray L; Sougakoff W; Robert J; Aubry A; ;
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33926973
    [No Abstract]   [Full Text] [Related]  

  • 14. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
    Sharma SK; Dheda K
    Indian J Med Res; 2019 Mar; 149(3):309-312. PubMed ID: 31249191
    [No Abstract]   [Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Hong-min W; Xiao-Hong Z
    Clin Infect Dis; 2015 Apr; 60(8):1285-6. PubMed ID: 25552551
    [No Abstract]   [Full Text] [Related]  

  • 17. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tuberculosis].
    Lange C; Kalsdorf B; Maurer FP; Heyckendorf J
    Internist (Berl); 2019 Nov; 60(11):1155-1175. PubMed ID: 31641790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.